Amgen
IPOA worldwide pioneer in biotechnology
Public · Thousand Oaks, United States · Founded 1980 · $19.0M raised
- Headquarters
- Thousand Oaks, California
- Employees
- 10001+
- Founded
- 1980
- Business Model
- B2B
- Website
- amgen.com
- Total Funding
- $19.0M
- Last Round
- $19.0M Venture RoundApr 1980
- Rounds
- 1
- Type
- Public
About
Amgen is a multinational biopharmaceutical company and pioneer of the biotechnology industry, founded in 1980 in Thousand Oaks, California. The company uses human genetic data and cutting-edge biology to discover and manufacture innovative medicines targeting serious illnesses including cancer, cardiovascular disease, osteoporosis, and inflammatory conditions. Amgen's portfolio spans both novel biologics and biosimilars, reaching millions of patients across more than 100 countries. With over 40 years of experience in recombinant DNA technology, Amgen remains one of the world's largest independent biotechnology companies.
Summary
Amgen is a Biotech company based in Thousand Oaks, United States, founded in 1980. It has raised $19.0M in total across 1 round, most recently a $19.0M Venture Round round in Apr 1980. Investors include William K. Bowes.
Tech & App Stack
22 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 1983
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...